ETF Holdings Breakdown of ADMA

Stock Name	ADMA Biologics Inc
Ticker	ADMA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US0008991046

ADMA institutional holdings

The following institutional investment holdings of ADMA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-17 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 53,016 USD 761,310

2025-10-17 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 152,344 USD 2,187,660

2025-10-17 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 152,344 USD 2,187,660

2025-10-17 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 166,438 USD 2,390,050 -5.1%

2025-10-17 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,005 USD 14,432 -5.1%

Total = 525,147 USD 7,541,112
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	53,016	USD 761,310
2025-10-17	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	152,344	USD 2,187,660
2025-10-17	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	152,344	USD 2,187,660
2025-10-17	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	166,438	USD 2,390,050 -5.1%
2025-10-17	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,005	USD 14,432 -5.1%
Total =	525,147	USD 7,541,112

News associated with ADMA

Charles Schwab Investment Management Inc. Raises Position in ADMA Biologics Inc (NASDAQ:ADMA): Charles Schwab Investment Management Inc. boosted its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 2,462,005 shares of the biotechnology company’s stock after buying an additional 21,711 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ADMA Biologics were worth […] - 2025-08-17 06:22:54
PNC Financial Services Group Inc. Increases Stake in ADMA Biologics Inc (NASDAQ:ADMA): PNC Financial Services Group Inc. raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 24.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,325 shares of the biotechnology company’s stock after acquiring an additional 4,553 shares during the […] - 2025-08-14 04:55:07
Harvest Fund Management Co. Ltd Takes Position in ADMA Biologics Inc (NASDAQ:ADMA): Harvest Fund Management Co. Ltd bought a new stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 2,611 shares of the biotechnology company’s stock, valued at approximately $52,000. A number of other hedge funds and other institutional investors have also recently made changes […] - 2025-08-01 05:32:51
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 14.5% in the first quarter, HoldingsChannel reports. The firm owned 68,686 shares of the biotechnology company’s stock after purchasing an additional 8,682 shares during the quarter. Envestnet Asset Management Inc.’s holdings in ADMA Biologics were worth $1,363,000 […] - 2025-08-01 04:36:52
Skandinaviska Enskilda Banken AB publ Invests $35,000 in ADMA Biologics Inc (NASDAQ:ADMA): Skandinaviska Enskilda Banken AB publ purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, HoldingsChannel reports. The firm purchased 1,773 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other hedge funds have also modified their holdings of ADMA. Vanguard Group Inc. […] - 2025-07-31 05:57:11
Avantax Advisory Services Inc. Has $2.15 Million Stake in ADMA Biologics Inc (NASDAQ:ADMA): Avantax Advisory Services Inc. lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 1.8% during the 1st quarter, HoldingsChannel reports. The fund owned 108,327 shares of the biotechnology company’s stock after purchasing an additional 1,954 shares during the period. Avantax Advisory Services Inc.’s holdings in ADMA Biologics were worth $2,149,000 […] - 2025-07-31 05:16:47
Cerity Partners LLC Acquires 4,575 Shares of ADMA Biologics Inc (NASDAQ:ADMA): Cerity Partners LLC boosted its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 10.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 47,703 shares of the biotechnology company’s stock after buying an additional 4,575 shares during the quarter. Cerity Partners LLC’s holdings in ADMA Biologics were worth $946,000 as […] - 2025-07-24 04:32:54
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The firm owned 34,423 shares of the biotechnology company’s stock after selling 1,384 shares during the quarter. Mutual of America Capital Management LLC’s holdings in ADMA Biologics […] - 2025-07-22 07:10:54
Bank of New York Mellon Corp Decreases Holdings in ADMA Biologics Inc (NASDAQ:ADMA): Bank of New York Mellon Corp cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,468,609 shares of the biotechnology company’s stock after selling 52,557 shares during the quarter. Bank […] - 2025-07-17 04:42:50
ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Principal Financial Group Inc.: Principal Financial Group Inc. boosted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,288,121 shares of the biotechnology company’s stock after purchasing an additional 29,107 […] - 2025-07-09 05:45:05
Robeco Institutional Asset Management B.V. Boosts Holdings in ADMA Biologics Inc (NASDAQ:ADMA): Robeco Institutional Asset Management B.V. lifted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 48.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 258,609 shares of the biotechnology company’s stock after buying an additional 84,125 shares during the […] - 2025-07-01 05:25:03
ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund decreased its position in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 17.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 105,223 shares of the biotechnology company’s stock after selling 21,937 shares during the period. Illinois Municipal Retirement Fund’s holdings in ADMA […] - 2025-06-30 05:38:52
Moran Wealth Management LLC Invests $795,000 in ADMA Biologics Inc (NASDAQ:ADMA): Moran Wealth Management LLC purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 40,056 shares of the biotechnology company’s stock, valued at approximately $795,000. A number of other large investors […] - 2025-06-27 05:14:54
State of Alaska Department of Revenue Sells 3,365 Shares of ADMA Biologics Inc (NASDAQ:ADMA): State of Alaska Department of Revenue reduced its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,981 shares of the biotechnology company’s stock after selling 3,365 shares during the period. […] - 2025-06-23 04:46:52
ADMA Biologics Inc (NASDAQ:ADMA) Director Sells $3,941,719.76 in Stock: ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 194,749 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $20.24, for a total transaction of $3,941,719.76. Following the transaction, the director now owns 87,330 shares in the company, valued at […] - 2025-06-20 05:14:53
Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA) Director Sells 137,931 Shares of Stock: ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 137,931 shares of ADMA Biologics stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $20.82, for a total value of $2,871,723.42. Following the completion of the sale, the director now owns 282,079 shares of the […] - 2025-06-19 05:11:05
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 6.8% on Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) shares traded down 6.8% on Tuesday following insider selling activity. The company traded as low as $19.17 and last traded at $19.01. 1,700,847 shares traded hands during trading, a decline of 54% from the average session volume of 3,667,821 shares. The stock had previously closed at $20.40. […] - 2025-06-19 02:13:07
Rhumbline Advisers Buys 1,088 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): Rhumbline Advisers raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.2% in the 1st quarter, Holdings Channel reports. The firm owned 622,167 shares of the biotechnology company’s stock after purchasing an additional 1,088 shares during the quarter. Rhumbline Advisers’ holdings in ADMA Biologics were worth $12,344,000 at the end […] - 2025-06-09 05:26:49
Wellington Management Group LLP Sells 13,834 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): Wellington Management Group LLP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,459 shares of the biotechnology company’s stock after selling 13,834 shares during the quarter. Wellington Management Group […] - 2025-06-06 05:04:51
California State Teachers Retirement System Acquires 8,717 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): California State Teachers Retirement System grew its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,391 shares of the biotechnology company’s stock after purchasing an additional 8,717 […] - 2025-06-05 05:33:03
B. Riley Wealth Advisors Inc. Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA): B. Riley Wealth Advisors Inc. lowered its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 31.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,614 shares of the biotechnology company’s stock after selling 5,892 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in ADMA Biologics were worth […] - 2025-06-02 05:40:55
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.77 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 511,526 shares of the biotechnology company’s stock after acquiring an additional 1,559 shares during […] - 2025-06-01 05:37:02
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Tidal Investments LLC: Tidal Investments LLC lessened its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,351 shares of the biotechnology company’s stock after selling 7,983 shares during the quarter. Tidal Investments LLC’s holdings […] - 2025-05-29 05:10:54
Janus Henderson Group PLC Acquires 15,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA): Janus Henderson Group PLC raised its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 107,161 shares of the biotechnology company’s stock after purchasing an additional 15,000 shares during the period. Janus Henderson Group PLC’s […] - 2025-05-22 06:14:47
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.56 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% during the 4th quarter, Holdings Channel reports. The firm owned 148,638 shares of the biotechnology company’s stock after purchasing an additional 10,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-21 06:14:52
ADMA Biologics (NASDAQ:ADMA) Cut to Sell at StockNews.com: StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Friday morning. Other equities analysts have also issued reports about the stock. Raymond James boosted their price objective on shares of ADMA Biologics from $25.00 to $32.00 and gave the stock […] - 2025-05-12 02:52:44
33,419 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Mariner LLC: Mariner LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,419 shares of the biotechnology company’s stock, valued at approximately $573,000. A number of other hedge funds have also added to […] - 2025-05-01 05:55:00
Vanguard Group Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA): Vanguard Group Inc. increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,198,796 shares of the biotechnology company’s stock after buying an additional 80,302 shares during the quarter. Vanguard […] - 2025-04-04 05:04:57
Corebridge Financial Inc. Lowers Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA): Corebridge Financial Inc. lowered its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 120,299 shares of the biotechnology company’s stock after selling 9,277 shares during the quarter. Corebridge […] - 2025-04-02 05:27:15
KLP Kapitalforvaltning AS Buys New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA): KLP Kapitalforvaltning AS bought a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 46,300 shares of the biotechnology company’s stock, valued at approximately $794,000. A number of other large investors have also recently added to or reduced their stakes in the company. Lord […] - 2025-04-01 05:14:51

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.